Blog

Aaron Goodman: This is nice paper that goes over differentiation syndrome associated with IDH1/2 inhibitors

Photo taken from aacrjournals.org

Apr 26, 2024, 06:18

Aaron Goodman: This is nice paper that goes over differentiation syndrome associated with IDH1/2 inhibitors

Aaron Goodman shared on X:

“This is nice paper that goes over differentiation syndrome associated with IDH1/2 inhibitors. Useful clinical stuff like time to onset and more.”

Additional information.
Source: Aaron Goodman/X

Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.

Aaron Goodman cancer Differentiation syndrome IDH1/2 inhibitors National Comprehensive Cancer Network NCCN OncoDaily Oncology University of California

Beyond the Red Carpet: Oscar Winners and Nominees Who Fought Cancer

Oncologist Near Me – Lidia Schapira: A Leader in Cancer Care and Medical Education

CancerWorld welcomes their Co-Editors-in-Chief

Dr. Manette Le Grange joins OncoDaily Editorial Board

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma